These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31112719)

  • 1. Advances in phenylboronic acid-based closed-loop smart drug delivery system for diabetic therapy.
    Huang Q; Wang L; Yu H; Ur-Rahman K
    J Control Release; 2019 Jul; 305():50-64. PubMed ID: 31112719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in Phenylboronic Acid-Based Gels with Potential for Self-Regulated Drug Delivery.
    Wang C; Lin B; Zhu H; Bi F; Xiao S; Wang L; Gai G; Zhao L
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30893913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose Responsive Rheological Change and Drug Release from a Novel Worm-like Micelle Gel Formed in Cetyltrimethylammonium Bromide/Phenylboronic Acid/Water System.
    Miki R; Takei C; Ohtani Y; Kawashima K; Yoshida A; Kojima Y; Egawa Y; Seki T; Iohara D; Anraku M; Hirayama F; Uekama K
    Mol Pharm; 2018 Mar; 15(3):1097-1104. PubMed ID: 29411982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual self-regulated delivery of insulin and glucagon by a hybrid patch.
    Wang Z; Wang J; Li H; Yu J; Chen G; Kahkoska AR; Wu V; Zeng Y; Wen D; Miedema JR; Buse JB; Gu Z
    Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29512-29517. PubMed ID: 33177238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioresponsive Functional Phenylboronic Acid-Based Delivery System as an Emerging Platform for Diabetic Therapy.
    Ma Q; Zhao X; Shi A; Wu J
    Int J Nanomedicine; 2021; 16():297-314. PubMed ID: 33488074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A stimuli-responsive insulin delivery system based on reversible phenylboronate modified cyclodextrin with glucose triggered host-guest interaction.
    Xu X; Shang H; Zhang T; Shu P; Liu Y; Xie J; Zhang D; Tan H; Li J
    Int J Pharm; 2018 Sep; 548(1):649-658. PubMed ID: 29981896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-nanoemulsifying drug delivery systems for oral insulin delivery: in vitro and in vivo evaluations of enteric coating and drug loading.
    Li P; Tan A; Prestidge CA; Nielsen HM; Müllertz A
    Int J Pharm; 2014 Dec; 477(1-2):390-8. PubMed ID: 25455781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A totally synthetic glucose responsive gel operating in physiological aqueous conditions.
    Matsumoto A; Yamamoto K; Yoshida R; Kataoka K; Aoyagi T; Miyahara Y
    Chem Commun (Camb); 2010 Apr; 46(13):2203-5. PubMed ID: 20234906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug delivery systems for the treatment of diabetes mellitus: state of the art.
    Adams GG; Harding SE
    Curr Pharm Des; 2013; 19(41):7244-63. PubMed ID: 23489203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenylboronic acid-functionalized glycopolymeric nanoparticles for biomacromolecules delivery across nasal respiratory.
    Zhang X; Wang Y; Zheng C; Li C
    Eur J Pharm Biopharm; 2012 Sep; 82(1):76-84. PubMed ID: 22659236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of inhaled insulin.
    Mastrandrea LD; Quattrin T
    Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1061-75. PubMed ID: 17070613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylboronic acid grafted chitosan as a glucose-sensitive vehicle for controlled insulin release.
    Wu Z; Zhang S; Zhang X; Shu S; Chu T; Yu D
    J Pharm Sci; 2011 Jun; 100(6):2278-86. PubMed ID: 21268025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injectable and biodegradable phospholipid-based phase separation gel for sustained delivery of insulin.
    Zhang T; Luo J; Peng Q; Dong J; Wang Y; Gong T; Zhang Z
    Colloids Surf B Biointerfaces; 2019 Apr; 176():194-201. PubMed ID: 30616110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biotechnological and administration innovations in insulin therapy].
    Verge D
    Med Sci (Paris); 2004 Nov; 20(11):986-98. PubMed ID: 15525494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress in therapy for diabetes mellitus--intensified insulin therapy].
    Yamada K
    Nihon Naika Gakkai Zasshi; 2009 Apr; 98(4):750-5. PubMed ID: 19472526
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro and in vivo evaluation of thermosensitive chitosan hydrogel for sustained release of insulin.
    Ghasemi Tahrir F; Ganji F; Mani AR; Khodaverdi E
    Drug Deliv; 2016; 23(3):1038-46. PubMed ID: 25005583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of pluronic- and methylcellulose-based thermoreversible drug delivery system for insulin.
    Nasir F; Iqbal Z; Khan A; Khan JA; Khan A; Khuda F; Zakir S; Yousaf N; Khan I; Shah Y; Khan MI; Shahbaz N
    Drug Dev Ind Pharm; 2014 Nov; 40(11):1503-8. PubMed ID: 23984755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An injectable particle-hydrogel hybrid system for glucose-regulatory insulin delivery.
    Zhao F; Wu D; Yao D; Guo R; Wang W; Dong A; Kong D; Zhang J
    Acta Biomater; 2017 Dec; 64():334-345. PubMed ID: 28974477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide drug delivery strategies for the treatment of diabetes.
    Sadrzadeh N; Glembourtt MJ; Stevenson CL
    J Pharm Sci; 2007 Aug; 96(8):1925-54. PubMed ID: 17286287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Closed-loop insulin delivery - what lies between where we are and where we are going?
    Steil GM; Rebrin K
    Expert Opin Drug Deliv; 2005 Mar; 2(2):353-62. PubMed ID: 16296759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.